NCT06991738 2026-03-18
177Lu-DOTA-EB-TATE in Adult Patients With Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid Cancer
National Institutes of Health Clinical Center (CC)
Phase 1/2 Not yet recruiting
Clinical Trials
8 trialsNCT07459283 2026-03-10
The Safety, Dosimetry and Efficacy of 177Lu-INN805 in Patients With Malignant Solid Tumors
FindCure Biosciences (ZhongShan) Co., Ltd.
Phase EARLY_PHASE1 Not yet recruiting
NCT07193186 2026-02-27
Anlotinib and Benmelstobart in DTC
Fudan University
Phase 2 Not yet recruiting
NCT07406087 2026-02-25
Navigation Intervention for Adolescent and Young Adult Cancer Survivors
Kaiser Permanente
Phase NA Not yet recruiting
NCT07405320 2026-02-12
A Brief Video Intervention to Improve Patient Outcomes Following Radioiodine Treatment
University of Auckland, New Zealand
Phase NA Not yet recruiting
NCT06647602 2026-02-10
THRIVE
University Medical Center Groningen
Not yet recruiting
NCT07225309 2026-01-26
A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer
Memorial Sloan Kettering Cancer Center
Phase NA Not yet recruiting
NCT07218315 2026-01-09
Nanosecond Pulsed Field Ablation in the Management of T1N0M0 Papillary Thyroid Carcinoma
M.D. Anderson Cancer Center
Phase NA Not yet recruiting